AbbVie Inc

(ABBV)

Health Care · Pharmaceutical Preparations · US

221.23

-1.2400 (-0.56%)

FINNHUB · 2h ago
Valuation Chart
Financial Statements
EDGAR · 1d ago
Line (USD)FY2025FY2024FY2023FY2022
Revenue61.16B56.33B54.32B58.05B
Operating Income15.08B9.14B12.76B18.12B
Interest Expense2.89B2.81B2.22B2.23B
Pretax Income6.60B3.72B6.25B13.48B
Income Tax2.36B-570.00M1.38B1.63B
Net Income4.23B4.28B4.86B11.84B
EPS (diluted)2.362.392.726.63
Diluted Shares1.77B1.77B1.77B1.78B
About

Employees: —
Key Ratios (TTM)
P/E93.96x
EV/EBITDA30.01x
EV/Sales7.40x
P/B
P/FCF22.07x
Operating margin24.6 %
Net margin6.9 %
ROE
Debt / Equity
Dividend yield
Revenue growth (YoY)8.6 %
EPS growth (YoY)-1.3 %
Beta
EDGAR · 1d ago
News
An unhandled error has occurred. Reload 🗙

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.